pumecitinib gel (PG-011 gel)
/ Prime Gene Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 20, 2024
A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P3 | N=472 | Recruiting | Sponsor: Prime Gene Therapeutics Co., Ltd.
New P3 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1